Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03651206
What this trial is testing

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Who this might be right for
Ovarian CarcinosarcomaEndometrial Carcinosarcoma
ARCAGY/ GINECO GROUP 138
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT00095979
What this trial is testing

Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Endometrial CarcinomaStage IV Endometrial Carcinoma
National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT02922764
What this trial is testing

RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more
Inspirna, Inc. 146
Testing effectiveness (Phase 2)Study completedNCT00392769
What this trial is testing

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Looking for participantsNCT06532539
What this trial is testing

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Who this might be right for
Endometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Testing effectiveness (Phase 2)Ended earlyNCT05263492
What this trial is testing

Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

Who this might be right for
Endometrial CancerMismatch Repair-ProficientRecurrent Endometrial Cancer
Virginia Commonwealth University 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT02912572
What this trial is testing

Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer

Who this might be right for
Metastatic Endometrial Cancer
Dana-Farber Cancer Institute 106
Testing effectiveness (Phase 2)Study completedNCT00006005
What this trial is testing

Thalidomide in Treating Patients With Gynecologic Sarcomas

Who this might be right for
Endometrial CancerSarcoma
New York University Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT03485729
What this trial is testing

ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
Jazz Pharmaceuticals 27
Large-scale testing (Phase 3)Study completedNCT00002641
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 350
Not applicableEnded earlyNCT00669422
What this trial is testing

ChemoFx® PRO - A Post-Market Data Collection Study

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Precision Therapeutics 2,756
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT03395080
What this trial is testing

DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma

Who this might be right for
Endometrial CancerUterine CancerOvarian Cancer+1 more
Leap Therapeutics, Inc. 111
Large-scale testing (Phase 3)Study completedNCT03555422
What this trial is testing

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 263
Testing effectiveness (Phase 2)Looking for participantsNCT07139977
What this trial is testing

Study of EV for Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
William Bradley 12
Testing effectiveness (Phase 2)Study completedNCT01367002
What this trial is testing

Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer

Who this might be right for
Endometrial Cancer
Yale University 61
Testing effectiveness (Phase 2)Study completedNCT00910091
What this trial is testing

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Ipsen 73
Next Page